Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure Pharmaceuticals to increase access to the weight-loss treatment in the nation. Emcure, ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, ...
Shares of Emcure Pharmaceuticals Ltd surged 8.04 per cent on Monday, touching an intraday high of Rs 1,448, before closing 7.03 per cent higher at Rs 1,434.50. The stock has gained 52.76 per cent over ...
Emcure Pharmaceuticals saw its shares reach the upper circuit limit of 10 percent on Friday, May 23, 2025, continuing a rally for the third day in a row with an impressive overall gain of nearly 20 ...
Emcure Pharmaceuticals has launched its IPO valued at ₹1,952.03 crores. Today is the final day of bidding for the IPO. It consists of a fresh issue of 0.79 crore shares aggregating to ₹800 crore and ...
Nov 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has partnered with India's Emcure Pharmaceuticals (EMCU.NS), opens new tab to exclusively distribute and market its weight-loss drug under a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results